Health Affairs October 25, 2024
Jeffrey G. Willett, Maher Karam-Hage

For six decades following the 1964 surgeon general’s report on smoking, public health and industry have implemented opposing strategies regarding the marketing and sale of tobacco products. Despite progress, smoking-attributable mortality remains a leading cause of preventable death, and concerning disparities in tobacco use prevalence exist, particularly among the 28.3 million US adults who smoke cigarettes. Recently, the emergence of e-cigarettes, oral nicotine pouches, and other novel tobacco products have created intense disagreements regarding how tobacco control can best improve public health. In this environment, decisions being made by policy makers, regulators, and industry will determine whether the US will continue to see a slow and inequitable reduction in tobacco-related deaths, or bolder action is taken to more rapidly reduce...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Healthcare System, Public Health / COVID
Why are women getting long COVID more than men?
How Climate-Driven Disasters Could Reshape Health Care Quality Measures
Journalists Discuss Health Care for Incarcerated Children and the Possibility of a Bird Flu Pandemic
What Is HKU5-CoV-2? Scientists Find Bat Virus Similar To COVID-19
Insights into the future of COVID-19 care

Share This Article